IQVIA (IQV) stock: analyst price target and their real reliability
Live quote · data updated Aug 28, 2026
IQVIA · Health Care · ref. ETF XLV · 62 calls · price $262.38
What the company does: IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.
📈 IQVIA (IQV) stock price
$262.38+39.0% over range
Aug 28, 25low $156.66 · high $262.38Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
90% recommend buying · 10 analysts
📊 JPI status : IQVIA has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
⚠️ The stock trades above the median target: it has beaten expectations. The “Buy” reflects conviction on the company, but the remaining quantified upside is low/negative.
🎯 IQV price target & analyst consensus — price $262
The price target · all analysts combined (10 targets)
Highest target · 1 firm of 10$288+9.8%
Median target · of 10 targets$258.5-1.5%
Lowest target · 1 firm of 10$185-29.5%
Current price$262.38
Where these 10 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
550%
$270 ↔ $288
Below
550%
$185 ↔ $247
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: BMO Capital — 73% of its targets hit on this sector (239 calls tested). It aims for $270 (+2.9 %), call made on July 30, 2026, maturing on July 30, 2027 (29 d ago).
The 7 reliable analysts
$276+5.2 %
The 3 other firms
$210-20 %
How to read it: the 7 reliable firms are not filtered by optimism — 5 aim above the price, 2 below, hence their $276 median. “The 3 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 10 ratings (last 6 months)
Strong Buy00%
Buy990%
Hold110%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 IQV price target all
All 62 calls, one by one, with our verdict on each firm.
→ See all 62 targets, analyst by analyst💡 The best analysts on IQV most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in IQV? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about IQVIA? The JPI assistant answers using our backtest data.
📈 IQVIA fundamentals: valuation, margins & growth › open the full page
P/E 32.6Net margin 8.1 %Revenue growth +8.7 %High P/E
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2022
marg. 8 %
2023
Rev +4%Profit +24%
2024
Rev +3%Profit +1%
2025
Rev +6%Profit −1%
🔎 Detailed analyses
🏛️ Which US Congress members hold IQVIA (IQV)?
2 Congress members have disclosed IQV buys. Click a highlighted name to see their track record (do they beat the S&P 500?).
Susie Lee 3× · 43%Kevin Hern 3× · 48%
✅ Historical analyst reliability on IQV
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| SunTrust Robinson Humphrey | 100% | +69.1% | 3 |
| CFRA | 100% | +47.0% | 2 |
| Raymond James ↗ | 100% | +40.8% | 2 |
| B of A Securities ↗ | 100% | +38.0% | 3 |
| Wells Fargo ↗ | 100% | +32.8% | 5 |
| Stephens & Co. ↗ | 100% | +10.7% | 2 |
| SVB Leerink | 100% | +4.3% | 2 |
| Baird ↗ | 83% | +20.2% | 6 |
| Citigroup ↗ | 80% | +30.2% | 5 |
| Guggenheim ↗ | 75% | +11.6% | 4 |
See the other 17 firms
| Keybanc ↗ | 20% | -12.2% | 5 |
| Credit Suisse | 20% | +12.0% | 5 |
| Evercore ISI Group ↗ | 29% | -7.3% | 7 |
| Truist Securities ↗ | 38% | -1.4% | 16 |
| Deutsche Bank ↗ | 38% | +4.7% | 8 |
| Leerink Partners ↗ | 50% | -5.6% | 2 |
| BTIG ↗ | 50% | -3.2% | 2 |
| RBC Capital ↗ | 50% | -2.8% | 6 |
| Barclays ↗ | 50% | +2.2% | 24 |
| JP Morgan ↗ | 50% | +4.8% | 8 |
| Argus Research ↗ | 50% | +9.2% | 4 |
| Morgan Stanley ↗ | 55% | +9.0% | 20 |
| UBS ↗ | 56% | +11.5% | 9 |
| Mizuho ↗ | 58% | +5.9% | 12 |
| Goldman Sachs ↗ | 67% | +5.1% | 3 |
| Jefferies ↗ | 67% | +43.0% | 3 |
| Stifel ↗ | 71% | +28.7% | 7 |
📊 What $1,000 invested in IQVIA would be worth › open the full page
In short — $1,000 invested in IQVIA 10 years ago would be worth $2,814 today, i.e. +11%/yr on average. Best year: 2021 (+57%), worst: 2022 (-27%). Price performance, excluding dividends.
If I'd invested $1,000 in IQVIA
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $983 | -2% |
| 3 years ago | $943 | -6% |
| 5 years ago | $1,078 | +8% |
Return by year (IQVIA)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | -14% | $857 (-14%) |
| 2025 | +15% | $983 (-2%) |
| 2024 | -15% | $835 (-16%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on IQVIA
Loading news…
📋 All analyst calls on IQV
Filtered on — · ✕ show all
▲ Overweight · 🎯$285
Price at call : $237.79 — upside +20%
Today : $262.38 — upside +9%
🎯 on IQV : 100% (1 call matured) · 📊 on Health : 53.8% · +5.3% (355 calls)
in progress (365j)
matures : Jul 29, 27
matures : Jul 29, 27
▲ Buy · 🎯$276
Price at call : $237.79 — upside +16%
Today : $262.38 — upside +5%
🎯 on IQV : no call matured yet · 📊 on Health : 51.2% · +8.1% (299 calls)
in progress (365j)
matures : Jul 29, 27
matures : Jul 29, 27
▲ Buy · 🎯$288
Price at call : $237.79 — upside +21%
Today : $262.38 — upside +10%
🎯 on IQV : no call matured yet · 📊 on Health : 49% · +1.0% (96 calls)
in progress (365j)
matures : Jul 29, 27
matures : Jul 29, 27
RBC Capital ↗
Jul 29, 26
▲ Outperform · 🎯$247
Price at call : $237.79 — upside +4%
Today : $262.38 — upside -6%
🎯 on IQV : no call matured yet · 📊 on Health : 42.8% · -2.4% (395 calls)
in progress (365j)
matures : Jul 29, 27
matures : Jul 29, 27
BMO Capital ↗
Jul 29, 26
▲ Outperform · 🎯$270
Price at call : $237.79 — upside +14%
Today : $262.38 — upside +3%
🎯 on IQV : no call matured yet · 📊 on Health : 60.7% · +8.8% (239 calls)
in progress (365j)
matures : Jul 29, 27
matures : Jul 29, 27
▲ Outperform · 🎯$287
Price at call : $247.56 — upside +16%
Today : $262.38 — upside +9%
🎯 on IQV : no call matured yet · 📊 on Health : 51.7% · +6.5% (298 calls)
in progress (365j)
matures : Jul 29, 27
matures : Jul 29, 27
▲ Outperform · 🎯$230
Price at call : $207.55 — upside +11%
Today : $262.38 — upside -12%
🎯 on IQV : 100% (2 calls matureds) · 📊 on Health : 52.1% · +3.5% (217 calls)
in progress (365j)
matures : Jul 13, 27
matures : Jul 13, 27
▲ Outperform · 🎯$249
Price at call : $203.2 — upside +23%
Today : $262.38 — upside -5%
🎯 on IQV : no call matured yet · 📊 on Health : 51.7% · +6.5% (298 calls)
in progress (365j)
matures : Jul 1, 27
matures : Jul 1, 27
See the other 54 calls, newest to oldest
Morgan Stanley ↗
Jun 17, 26
■ Equal-Weight neutral · not a buy · 🎯$200
Price at call : $170.67 — gap to target +17%
Today : $262.38 — gap to target -24%
🎯 on IQV : no call matured yet · 📊 on Health : 51.5% · +5.2% (825 calls)
in progress (365j)
matures : Jun 17, 27
matures : Jun 17, 27
Evercore ISI Group ↗
Apr 8, 26
▲ Outperform · 🎯$185
Price at call : $168.98 — upside +9%
Today : $262.38 — upside -29%
🎯 on IQV : 100% (1 call matured) · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Apr 8, 27
matures : Apr 8, 27
▲ Buy · 🎯$213
Price at call : $170.93 — upside +25%
Today : $262.38 — upside -19%
🎯 on IQV : no call matured yet · 📊 on Health : 49% · +1.0% (96 calls)
in progress (365j)
matures : Mar 9, 27
matures : Mar 9, 27
▲ Overweight · 🎯$210
Price at call : $174.49 — upside +20%
Today : $262.38 — upside -20%
🎯 on IQV : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Mar 6, 27
matures : Mar 6, 27
RBC Capital ↗
Mar 3, 26
▲ Outperform · 🎯$221
Price at call : $177.88 — upside +24%
Today : $262.38 — upside -16%
🎯 on IQV : no call matured yet · 📊 on Health : 42.8% · -2.4% (395 calls)
in progress (365j)
matures : Mar 3, 27
matures : Mar 3, 27
Truist Securities ↗
Feb 19, 26
▲ Buy · 🎯$245
Price at call : $165.62 — upside +48%
Today : $262.38 — upside -7%
🎯 on IQV : 33% (12 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
in progress (365j)
matures : Feb 19, 27
matures : Feb 19, 27
▲ Overweight · 🎯$225
Price at call : $192.67 — upside +17%
Today : $262.38 — upside -14%
🎯 on IQV : 100% (1 call matured) · 📊 on Health : 53.8% · +5.3% (355 calls)
in progress (365j)
matures : Feb 6, 27
matures : Feb 6, 27
■ Neutral neutral · not a buy · 🎯$200
Price at call : $192.67 — gap to target +4%
Today : $262.38 — gap to target -24%
🎯 on IQV : no call matured yet · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : Feb 6, 27
matures : Feb 6, 27
▲ Buy · 🎯$240
Price at call : $192.67 — upside +25%
Today : $262.38 — upside -9%
🎯 on IQV : 100% (2 calls matureds) · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Feb 6, 27
matures : Feb 6, 27
▲ Buy · 🎯$255
Price at call : $192.67 — upside +32%
Today : $262.38 — upside -3%
🎯 on IQV : no call matured yet · 📊 on Health : 50.8% · +4.5% (380 calls)
in progress (365j)
matures : Feb 6, 27
matures : Feb 6, 27
▲ Buy · 🎯$220
Price at call : $192.67 — upside +14%
Today : $262.38 — upside -16%
🎯 on IQV : no call matured yet · 📊 on Health : 51.2% · +8.1% (299 calls)
in progress (365j)
matures : Feb 6, 27
matures : Feb 6, 27
■ Equal-Weight neutral · not a buy · 🎯$210
Price at call : $192.67 — gap to target +9%
Today : $262.38 — gap to target -20%
🎯 on IQV : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Feb 6, 27
matures : Feb 6, 27
■ Hold neutral · not a buy · 🎯$245
Price at call : $235.31 — gap to target +4%
Today : $262.38 — gap to target -7%
🎯 on IQV : no call matured yet · 📊 on Health : 49% · +1.0% (96 calls)
in progress (365j)
matures : Jan 22, 27
matures : Jan 22, 27
Truist Securities ↗
Jan 8, 26
▲ Buy · 🎯$290
Price at call : $242.41 — upside +20%
Today : $262.38 — upside +11%
🎯 on IQV : 33% (12 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
in progress (365j)
matures : Jan 8, 27
matures : Jan 8, 27
▲ Buy · 🎯$280
Price at call : $242.41 — upside +16%
Today : $262.38 — upside +7%
🎯 on IQV : 100% (2 calls matureds) · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Jan 8, 27
matures : Jan 8, 27
Morgan Stanley ↗
Dec 2, 25
▲ Overweight · 🎯$265
Price at call : $227.24 — upside +17%
Today : $262.38 — upside +1%
🎯 on IQV : no call matured yet · 📊 on Health : 51.5% · +5.2% (825 calls)
in progress (365j)
matures : Dec 2, 26
matures : Dec 2, 26
BMO Capital ↗
Nov 13, 25
▲ Outperform · 🎯$260
Price at call : $223.55 — upside +16%
Today : $262.38 — upside -1%
🎯 on IQV : no call matured yet · 📊 on Health : 60.7% · +8.8% (239 calls)
in progress (365j)
matures : Nov 13, 26
matures : Nov 13, 26
■ Hold neutral · not a buy · 🎯$215
Price at call : $210.96 — gap to target +2%
Today : $262.38 — gap to target -18%
🎯 on IQV : no call matured yet · 📊 on Health : 49% · +1.0% (96 calls)
in progress (365j)
matures : Nov 3, 26
matures : Nov 3, 26
■ Neutral neutral · not a buy · 🎯$230
Price at call : $216.47 — gap to target +6%
Today : $262.38 — gap to target -12%
🎯 on IQV : no call matured yet · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : Oct 29, 26
matures : Oct 29, 26
▲ Buy · 🎯$250
Price at call : $216.47 — upside +15%
Today : $262.38 — upside -5%
🎯 on IQV : 100% (2 calls matureds) · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Oct 29, 26
matures : Oct 29, 26
▲ Buy · 🎯$254
Price at call : $216.47 — upside +17%
Today : $262.38 — upside -3%
🎯 on IQV : no call matured yet · 📊 on Health : 51.2% · +8.1% (299 calls)
in progress (365j)
matures : Oct 29, 26
matures : Oct 29, 26
Truist Securities ↗
Oct 29, 25
▲ Buy · 🎯$265
Price at call : $216.47 — upside +22%
Today : $262.38 — upside +1%
🎯 on IQV : 33% (12 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
in progress (365j)
matures : Oct 29, 26
matures : Oct 29, 26
▲ Overweight · 🎯$255
Price at call : $216.47 — upside +18%
Today : $262.38 — upside -3%
🎯 on IQV : 100% (1 call matured) · 📊 on Health : 53.8% · +5.3% (355 calls)
in progress (365j)
matures : Oct 29, 26
matures : Oct 29, 26
▲ Outperform · 🎯$258
Price at call : $217.83 — upside +18%
Today : $262.38 — upside -2%
🎯 on IQV : no call matured yet · 📊 on Health : 51.7% · +6.5% (298 calls)
in progress (365j)
matures : Oct 29, 26
matures : Oct 29, 26
▲ Buy · 🎯$235
Price at call : $203 — upside +16%
Today : $262.38 — upside -10%
🎯 on IQV : no call matured yet · 📊 on Health : 53.6% · +1.4% (28 calls)
in progress (365j)
matures : Oct 9, 26
matures : Oct 9, 26
Evercore ISI Group ↗
Oct 8, 25
▲ Outperform · 🎯$240
Price at call : $200.6 — upside +20%
Today : $262.38 — upside -9%
🎯 on IQV : 100% (1 call matured) · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Oct 8, 26
matures : Oct 8, 26
■ Equal-Weight neutral · not a buy · 🎯$200
Price at call : $206.63 — gap to target -3%
Today : $262.38 — gap to target -24%
🎯 on IQV : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Oct 2, 26
matures : Oct 2, 26
▲ Buy · 🎯$225
Price at call : $189.64 — upside +19%
Today : $262.38 — upside -14%
🎯 on IQV : no call matured yet · 📊 on Health : 50.8% · +4.5% (380 calls)
in progress (365j)
matures : Sep 9, 26
matures : Sep 9, 26
▲ Outperform · 🎯$225
Price at call : $197.76 — upside +14%
Today : $262.38 — upside -14%
Expected +14% · Actual +8% · Reason (≥ +15%) : ✗ No
🎯 on IQV : 100% (2 calls matureds) · 📊 on Health : 52.1% · +3.5% (217 calls)
+7.8%
stock +8% · XLV +21%
matured Jul 25, 26
■ Neutral neutral · not a buy · 🎯$200
Price at call : $200.82 — gap to target -0%
Today : $262.38 — gap to target -24%
🎯 on IQV : no call matured yet · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : Jul 23, 26
matures : Jul 23, 26
▲ Buy · 🎯$225
Price at call : $200.82 — upside +12%
Today : $262.38 — upside -14%
Expected +12% · Actual +4% · Reason (≥ +15%) : ✗ No
🎯 on IQV : 100% (2 calls matureds) · 📊 on Health : 51.5% · +3.1% (355 calls)
+3.6%
stock +4% · XLV +20%
matured Jul 23, 26
Truist Securities ↗
Jul 23, 25
▲ Buy · 🎯$235
Price at call : $200.82 — upside +17%
Today : $262.38 — upside -10%
Expected +17% · Actual +4% · Reason (≥ +15%) : ✗ No
🎯 on IQV : 33% (12 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
+3.6%
stock +4% · XLV +20%
matured Jul 23, 26
■ Equal-Weight neutral · not a buy · 🎯$185
Price at call : $194.24 — gap to target -5%
Today : $262.38 — gap to target -29%
🎯 on IQV : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Jul 23, 26
matures : Jul 23, 26
■ Neutral neutral · not a buy · 🎯$196
Price at call : $194.24 — gap to target +1%
Today : $262.38 — gap to target -25%
🎯 on IQV : no call matured yet · 📊 on Health : 51.7% · +6.5% (298 calls)
in progress (365j)
matures : Jul 23, 26
matures : Jul 23, 26
Evercore ISI Group ↗
Jul 9, 25
▲ Outperform · 🎯$180
Price at call : $162.02 — upside +11%
Today : $262.38 — upside -31%
Expected +11% · Actual +29% · Reason (≥ +15%) : ✓ Yes
🎯 on IQV : 100% (1 call matured) · 📊 on Health : 45.8% · +0.0% (168 calls)
+29.0%
stock +29% · XLV +20%
matured Jul 9, 26
▲ Overweight · 🎯$177
Price at call : $144.95 — upside +22%
Today : $262.38 — upside -33%
Expected +22% · Actual +18% · Reason (≥ +15%) : ✓ Yes
🎯 on IQV : 100% (1 call matured) · 📊 on Health : 53.8% · +5.3% (355 calls)
+18.3%
stock +18% · XLV +9%
matured May 19, 26
▲ Outperform · 🎯$190
Price at call : $142.82 — upside +33%
Today : $262.38 — upside -28%
Expected +33% · Actual +21% · Reason (≥ +15%) : ✓ Yes
🎯 on IQV : 100% (2 calls matureds) · 📊 on Health : 52.1% · +3.5% (217 calls)
+21.0%
stock +21% · XLV +9%
matured May 15, 26
■ Neutral neutral · not a buy · 🎯$160
Price at call : $153.29 — gap to target +4%
Today : $262.38 — gap to target -39%
🎯 on IQV : no call matured yet · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : May 7, 26
matures : May 7, 26
■ Neutral neutral · not a buy · 🎯$161
Price at call : $153.29 — gap to target +5%
Today : $262.38 — gap to target -39%
🎯 on IQV : no call matured yet · 📊 on Health : 51.7% · +6.5% (298 calls)
in progress (365j)
matures : May 7, 26
matures : May 7, 26
▲ Buy · 🎯$185
Price at call : $153.29 — upside +21%
Today : $262.38 — upside -29%
Expected +21% · Actual +17% · Reason (≥ +15%) : ✓ Yes
🎯 on IQV : 100% (2 calls matureds) · 📊 on Health : 51.5% · +3.1% (355 calls)
+16.6%
stock +17% · XLV +7%
matured May 7, 26
■ Equal-Weight neutral · not a buy · 🎯$165
Price at call : $153.3 — gap to target +8%
Today : $262.38 — gap to target -37%
🎯 on IQV : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : May 7, 26
matures : May 7, 26
■ Hold neutral · not a buy · 🎯$160
Price at call : $150.13 — gap to target +7%
Today : $262.38 — gap to target -39%
🎯 on IQV : no call matured yet · 📊 on Health : 53.6% · +1.4% (28 calls)
in progress (365j)
matures : Apr 25, 26
matures : Apr 25, 26
Truist Securities ↗
Apr 10, 25
▲ Buy · 🎯$216
Price at call : $143.22 — upside +51%
Today : $262.38 — upside -18%
Expected +51% · Actual +17% · Reason (≥ +15%) : ✓ Yes
🎯 on IQV : 33% (12 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
+16.8%
stock +17% · XLV +9%
matured Apr 10, 26
Truist Securities ↗
Feb 10, 25
▲ Buy · 🎯$263
Price at call : $206.97 — upside +27%
Today : $262.38 — upside +0%
Expected +27% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on IQV : 33% (12 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
-11.8%
stock -12% · XLV +6%
matured Feb 10, 26
Truist Securities ↗
Dec 12, 24
▲ Buy · 🎯$261
Price at call : $199.06 — upside +31%
Today : $262.38 — upside -1%
Expected +31% · Actual +12% · Reason (≥ +15%) : ✗ No
🎯 on IQV : 33% (12 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
+12.3%
stock +12% · XLV +11%
matured Dec 12, 25
Leerink Partners ↗
Nov 19, 24
▲ Outperform · 🎯$248
Price at call : $194.38 — upside +28%
Today : $262.38 — upside -5%
Expected +28% · Actual +12% · Reason (≥ +15%) : ✗ No
🎯 on IQV : 100% (1 call matured) · 📊 on Health : 55.3% · -4.8% (38 calls)
+11.7%
stock +12% · XLV +6%
matured Nov 19, 25
Truist Securities ↗
Nov 4, 24
▲ Buy · 🎯$265
Price at call : $212.87 — upside +24%
Today : $262.38 — upside +1%
Expected +24% · Actual -1% · Reason (≥ +15%) : ✗ No
🎯 on IQV : 33% (12 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
-1.3%
stock -1% · XLV -1%
matured Nov 4, 25
Truist Securities ↗
Oct 14, 24
▲ Buy · 🎯$286
Price at call : $232.98 — upside +23%
Today : $262.38 — upside +9%
Expected +23% · Actual -13% · Reason (≥ +15%) : ✗ No
🎯 on IQV : 33% (12 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
-12.8%
stock -13% · XLV -7%
matured Oct 14, 25
Truist Securities ↗
Jul 23, 24
▲ Buy · 🎯$300
Price at call : $238.75 — upside +26%
Today : $262.38 — upside +14%
Expected +26% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on IQV : 33% (12 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
-15.9%
stock -16% · XLV -9%
matured Jul 23, 25
Truist Securities ↗
May 3, 24
▲ Buy · 🎯$292
Price at call : $227.04 — upside +29%
Today : $262.38 — upside +11%
Expected +29% · Actual -33% · Reason (≥ +15%) : ✗ No
🎯 on IQV : 33% (12 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
-32.9%
stock -33% · XLV -2%
matured May 3, 25
Truist Securities ↗
Feb 27, 24
▲ Buy · 🎯$297
Price at call : $248.84 — upside +19%
Today : $262.38 — upside +13%
Expected +19% · Actual -23% · Reason (≥ +15%) : ✗ No
🎯 on IQV : 33% (12 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
-23.3%
stock -23% · XLV +1%
matured Feb 26, 25
Truist Securities ↗
Jan 4, 24
▲ Buy · 🎯$286
Price at call : $220.52 — upside +30%
Today : $262.38 — upside +9%
Expected +30% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on IQV : 33% (12 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
-9.6%
stock -10% · XLV -0%
matured Jan 3, 25
Truist Securities ↗
Nov 21, 23
▲ Buy · 🎯$240
Price at call : $209.52 — upside +15%
Today : $262.38 — upside -9%
Expected +15% · Actual -6% · Reason (≥ +15%) : ✗ No
🎯 on IQV : 33% (12 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
-5.7%
stock -6% · XLV +10%
matured Nov 20, 24
Truist Securities ↗
Oct 3, 23
▲ Buy · 🎯$260
Price at call : $196.43 — upside +32%
Today : $262.38 — upside -1%
Expected +32% · Actual +16% · Reason (≥ +15%) : ✓ Yes
🎯 on IQV : 33% (12 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
+15.8%
stock +16% · XLV +18%
matured Oct 2, 24
Frequently asked questions
Should I buy IQVIA stock?
This isn't buy advice. For IQVIA, the analyst consensus is "Buy", with an average price target of $259 (-1% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (3 calls tracked on IQVIA). We show the numbers — you decide.
Is it too late to buy IQVIA? How high can it go?
The most bullish analyst target on IQVIA is $288 (+10% above today's price); the average is $259. That's the upside they see. Check how reliable those analysts have actually been on IQVIA on our site before trusting it.
Is IQVIA still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 27 analysts have a real record on IQVIA, the best hitting 100% over 3 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in IQVIA? The case for and against
The arguments for and against, one by one, from the numbers: why invest in IQV (and why hesitate).
What has IQVIA's past performance been?
Historical returns and a "how much if I had invested" calculator: IQV performance & returns.
What is the best month to buy IQV?
The 12 months ranked by the stock's past returns: best & worst month to buy IQV.
BIIB 
VRTX 
UNH 
REGN 
EW 
SRPT 
VEEV 
BSX